AtriCure, Inc. (ATRC) Return on equity 2016–2025
AtriCure, Inc. (ATRC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-2.3%FY2025 · since FY2016: -19.8% → -2.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -2.3% | +7.4 pp |
| FY2024 | -9.7% | -3.2 pp |
| FY2023 | -6.5% | +3.6 pp |
| FY2022 | -10.2% | -20.6 pp |
| FY2021 | 10.4% | +22.1 pp |
| FY2020 | -11.7% | +2.6 pp |
| FY2019 | -14.2% | -5.8 pp |
| FY2018 | -8.5% | +8.2 pp |
| FY2017 | -16.7% | +3.1 pp |
| FY2016 | -19.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More ATRC financial trends
ATRC RevenueATRC Net incomeATRC Net marginATRC Gross profitATRC Gross marginATRC Operating incomeATRC Operating marginATRC Operating cash flowATRC Free cash flowATRC Capital expendituresATRC Stock buybacksATRC Dividends paidATRC Total assetsATRC Total liabilitiesATRC Shareholders’ equityATRC overview →